exRNAdisease

Entry Detail

---



General Information

Database ID: exR0356557 RNA Name: hsa-miR-21-5p RNA Type: miRNA Chromosome: chr17 Starnd: + Coordinate: Start Site(bp): 59841273 End Site(bp): 59841294 External Links: hsa-miR-21-5p

Disease Information

Disease Name: Breast Cancer Disease Category: Cancers MeSH ID: D001943 Type: Neoplasms/Breast Neoplasms Alias: Breast Neoplasms//Breast Neoplasm//Neoplasm, Breast//Breast Tumors//Breast Tumor//Tumor, Breast//Tumors, Breast//Neoplasms, Breast//Breast Cancer//Cancer, Breast//Mammary Cancer//Cancer, Mammary//Cancers, Mammary//Mammary Cancers//Malignant Neoplasm of Breast//Breast Malignant Neoplasm//Breast Malignant Neoplasms//Malignant Tumor of Breast//Breast Malignant Tumor//Breast Malignant Tumors//Cancer of Breast//Cancer of the Breast//Mammary Carcinoma, Human//Carcinoma, Human Mammary//Carcinomas, Human Mammary//Human Mammary Carcinomas//Mammary Carcinomas, Human//Human Mammary Carcinoma//Mammary Neoplasms, Human//Human Mammary Neoplasm//Human Mammary Neoplasms//Neoplasm, Human Mammary//Neoplasms, Human Mammary//Mammary Neoplasm, Human//Breast Carcinoma//Breast Carcinomas//Carcinoma, Breast//Carcinomas, Breast

Expression Detail

GEO ID: GSE98181 Description: Circulating miRNA profiles from serum of women at high-risk for breast cancer Experimental Design: Cancer vs Control Case Disease Type: Breast Cancer Case Disease SubType: NA Case Sample: Breast Cancer Control Sample: Healthy Number of Case: 24 Number of Control: 24 Number of Samples: 48

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand KAZN chr1 13892792 15118043 + UBE2T chr1 202331657 202341980 - CLEC2D chr12 9664969 9699553 + EIF4A2 chr3 186783205 186789897 + MGST1 chr12 16347142 16609259 + POLE3 chr9 113407235 113410675 - SOWAHC chr2 109614364 109618990 + OSER1 chr20 44195939 44210771 - EXOC4 chr7 133253073 134066589 + EDARADD chr1 236348257 236502915 + HNRNPA0 chr5 137745651 137754363 - GPSM3 chr6 32190766 32195523 - CTH chr1 70411218 70439851 + CITED2 chr6 139371807 139374648 - MTREX chr5 55307989 55425579 + AP3D1 chr19 2100988 2164468 - ELP2 chr18 36129444 36180557 + HSPA4 chr5 133052013 133106449 + RGS1 chr1 192575763 192580024 + HSD17B4 chr5 119452473 119637199 + ZFP36L1 chr14 68787660 68796253 - HMGA1 chr6 34236873 34246231 + EEF1B2 chr2 206159585 206162928 + DYNC1H1 chr14 101964573 102056443 + DUSP2 chr2 96143169 96145440 - MCRS1 chr12 49556544 49568145 - ATRX chrX 77504878 77786233 - ZADH2 chr18 75195113 75209139 - PLIN2 chr9 19108375 19149290 - TREX1 chr3 48465811 48467645 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001731 chr7 100731990 100738448 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC068768.1 chr12 123262060 123262402 + ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - OTUD6B-AS1 chr8 91059318 91070583 - SNHG1 chr11 62851984 62855953 - TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE98181 Sample Source: Blood Source Fraction: Serum Platform: GPL21572 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2546 Sample treatment protocol: Serum is obtained from coagulated whole blood samples by centrifugation at 3000 rpm for 10 minutes. RNA Extract protocol: RNA was isolated from a 200ul serum aliquot using the miRNeasy Serum Plasma kit with ce-miR-39 spike-in (QIAGEN), QIAcube (QIAGEN) automation, and eluted with 14uL of nuclease-free water. RNA library preparation protocol: Exactly 8ul of RNA was tagged with a Poly-A tail, using an ATP driven reaction from the Affymetrix® FlashTag™ Biotin HSR RNA Labeling Kit.

Reference

PMID: 29348816 Title: Development of a predictive miRNA signature for breast cancer risk among high-risk women. Author: Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME Journal: Oncotarget. 2017 Nov 28;8(68):112170-112183. Description: We evaluated the ability of C-miRNAs to identify women most likely to develop breast cancer by profiling miRNA from serum obtained long before diagnosis.